On December 7, 2023, the Biden administration announced a blueprint for a framework that may be a tough pill to swallow for the pharmaceutical industry. This framework suggests that drug prices should be a crucial factor in determining whether the public can access taxpayer-funded meds without breaking the bank. More strikingly, it allows government agencies to license the patents of these drugs to other parties if the original cost is deemed excessively high….
By: Seyfarth Shaw LLP
By: Seyfarth Shaw LLP
